跳至主要内容
临床试验/NCT05382611
NCT05382611已完成不适用

miRNA in Patients With Thoracic, Abdominal and Intracranial Aneurysms

Na Homolce Hospital1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2018年5月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
35
试验地点
1
主要终点
The comparison of miRNA in healthy and aneurysmatic tissue

研究概览

简要总结

To assess the expression of miRNA in patients with TAA, AAA in aneurysmatic tissue and to compare this expression with the healthy tissue in the same patient.

In the same cohort, to asses the presence of miRNA in plasma and to compare with the control group.

Over the period of three years,to follow subjects in order to assess if the presence of certain miRNAs speeds up or slows down the progression of disease.

In patients with intracranial aneurysms to detect miRNA in plasma especially in patients with familial occurrence.

详细描述

MicroRNAs constitute a recently discovered class of non-coding RNAs that play key roles in the regulation of gene expression. Acting at the post-transcriptional level, MicroRNAs have been shown to be involved in a wide range of biological processes such as cell cycle control, apoptosis and several developmental and physiological processes including stem cell differentiation, hematopoiesis, hypoxia, cardiac and skeletal muscle development. In addition to their important roles in healthy individuals, microRNAs have also been implicated in a number of diseases including a broad range of cancers, cardiovascular and heart disease. Their different expression in aortic tissue in patients with aortic abdominal aneurysm and their association with the progression of the disease were confirmed. They represent the potential target for the treatment of the disease. MiRNA act as biomarkers showing the potential risk of the presence of TAA, AAA and intracranial aneurysm, for the prediction of TAA and AAA progression and for the discovery of new treatment possibilities.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older
  • Patient willing and able to sign clinical trial Informed Consent
  • Patient with AAA or TAA who require an open surgical procedure, or patient with intracranial aneurysm indicated for radiological intervention

排除标准

  • Patient with multiorgan failure

结局指标

主要结局

The comparison of miRNA in healthy and aneurysmatic tissue

时间窗: 2020 at end of trial

miRNA will be compared in blood and in healthy and aneurysmatic tissue using ngs

次要结局

未报告次要终点

研究者

发起方
Na Homolce Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Assoc. Prof. Miroslav Prucha, M.D., PhD.

Assoc.Prof

Na Homolce Hospital

研究点 (1)

Loading locations...

相似试验

miRNA in Patients With Thoracic, Abdominal and... | 临床试验